Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Canadian REgistry of Chronic Kidney Disease in Diabetes Outcomes (CREDO) Study

NCT04445181 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT04445181
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04445181 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Canadian REgistry of Chronic Kidney Disease in Diabetes Outcomes (CREDO) Study
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
July 1, 2020
Completion date
November 23, 2020
Enrollment
14,873 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease in type 2 diabetes